Lower IL-22 may act as a biomarker of improved metabolic health rather than the direct cause, as seen in T2DM and Polycystic Ovary Syndrome (PCOS) where moderate exercise reduces inflammation and improves insulin sensitivity (17, 18). This evidence concerns the gene IL22 and polycystic ovary syndrome.